Suppr超能文献

原发性红斑性肢痛症患者中编码钠通道α亚基的SCN9A基因发生突变。

Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.

作者信息

Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, Fan J, Bu D, Liu B, Fan Z, Wu G, Jin J, Ding B, Zhu X, Shen Y

机构信息

Department of Dermatology, Peking University First Hospital, Beijing, China.

出版信息

J Med Genet. 2004 Mar;41(3):171-4. doi: 10.1136/jmg.2003.012153.

Abstract

Primary erythermalgia is a rare autosomal dominant disease characterised by intermittent burning pain with redness and heat in the extremities. A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified. We performed linkage analysis in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient. Linkage analysis yielded a maximum lod score of 2.11 for both markers D2S2370 and D2S2330. Based on critical recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345. We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C). Our data suggest that mutations in SCN9A cause primary erythermalgia. SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurones, may play an important role in nociception and vasomotor regulation.

摘要

原发性红斑性肢痛症是一种罕见的常染色体显性疾病,其特征为四肢间歇性灼痛伴发红和发热。先前的一项研究确定了原发性红斑性肢痛症与2号染色体长臂上一个7.94厘摩区间的连锁关系,但致病基因尚未确定。我们对一个患原发性红斑性肢痛症的中国家系进行了连锁分析,并对该家系及一名散发患者的两个候选基因SCN9A和GCA中的突变进行了筛查。连锁分析显示,标记D2S2370和D2S2330的最大对数优势得分为2.11。基于该家系两名患者中的关键重组事件,我们进一步将遗传区域限定在D2S2370和D2S2345之间的5.98厘摩。然后我们在该家系(T2573A)及散发患者(T2543C)中鉴定出SCN9A的两个错义突变。我们的数据表明,SCN9A突变导致原发性红斑性肢痛症。SCN9A编码一种主要在感觉神经元和交感神经元中表达的电压门控钠通道α亚基,可能在伤害感受和血管舒缩调节中起重要作用。

相似文献

2
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.
J Invest Dermatol. 2005 Jun;124(6):1333-8. doi: 10.1111/j.0022-202X.2005.23737.x.
7
A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Curr Mol Med. 2017;17(6):450-457. doi: 10.2174/1566524017666171009105029.
8
Characterization of a familial case with primary erythromelalgia from Taiwan.
J Neurol. 2007 Feb;254(2):210-4. doi: 10.1007/s00415-006-0328-3. Epub 2007 Feb 8.

引用本文的文献

1
Small fiber neuropathy: expanding diagnosis with unsettled etiology.
Curr Opin Neurol. 2025 Oct 1;38(5):485-495. doi: 10.1097/WCO.0000000000001418. Epub 2025 Aug 20.
3
Mimicking the Usual Suspects: Erythromelalgia in the Differential Diagnosis.
J Brown Hosp Med. 2025 Jul 1;4(3):137218. doi: 10.56305/001c.137218. eCollection 2025.
4
Comparative Efficacy and Tolerability of Treatments for Erythromelalgia: A Systematic Review.
Medicina (Kaunas). 2025 May 19;61(5):920. doi: 10.3390/medicina61050920.
5
Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine).
J Gen Physiol. 2025 Jul 7;157(4). doi: 10.1085/jgp.202513778. Epub 2025 Apr 28.
7
Primary Erythromelalgia: Historical Perspective and Current Update.
Cureus. 2025 Feb 5;17(2):e78576. doi: 10.7759/cureus.78576. eCollection 2025 Feb.
8
Small-Fiber Neuropathy: An Etiology-Oriented Review.
Brain Sci. 2025 Feb 6;15(2):158. doi: 10.3390/brainsci15020158.
9
Discordance between preclinical and clinical testing of Na V 1.7-selective inhibitors for pain.
Pain. 2025 Mar 1;166(3):481-501. doi: 10.1097/j.pain.0000000000003425. Epub 2024 Oct 23.
10
Voltage-gated sodium channels in excitable cells as drug targets.
Nat Rev Drug Discov. 2025 May;24(5):358-378. doi: 10.1038/s41573-024-01108-x. Epub 2025 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验